Reduction of overall OPN expression by the anti-OPN antibody therapy in ischemic stroke lesions was further confirmed for endothelial cells, pericytes, astrocytes and microglia/macrophages independently by immunofluorescence (Fig. 6a–d). This evidence concerns the gene SPP1 and ischemic stroke.